| Mitchell Mckee, AMFT | |
|
519 W State Rd Ste 102, Pleasant Grove, UT 84062-2158 | |
| (385) 312-9844 | |
| Not Available |
| Full Name | Mitchell Mckee |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 519 W State Rd Ste 102, Pleasant Grove, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952057721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mitchell Mckee, AMFT 519 W State Rd Ste 102, Pleasant Grove, UT 84062-2158 Ph: (385) 312-9844 | Mitchell Mckee, AMFT 519 W State Rd Ste 102, Pleasant Grove, UT 84062-2158 Ph: (385) 312-9844 |
News Archive
CEA-Leti and NEOLUX announced a new partnership aimed at developing and manufacturing innovative LED modules and products for lighting.
The Elsevier Foundation has announced the 2010 recipients of grants under its Innovative Libraries in Developing Countries program, committing over $300,000 to support the work of libraries in developing countries. The 2010 grant recipients were selected from 260 proposals worldwide for their innovation and potential for impact in the developing world. The Innovative Libraries program supports capacity-building projects in the science, technology and medicine library training, education, infrastructure, digitization and the preservation of information.
New data have been presented for the first time at the European Association of Dermato Oncology (EADO) Congress today on the investigational MEK inhibitor cobimetinib (GDC-0973) in combination with BRAFV600 inhibitor Zelboraf® (vemurafenib) for metastatic melanoma, the most aggressive form of skin cancer. The findings illustrate that cobimetinib and vemurafenib can be safely co-administered and that the combination shows promising anti-tumour activity, with a median progression-free survival (mPFS) of 13.7 months for BRAF inhibitor-naive patients.1
Atrial fibrillation is a condition that produces an irregular heartbeat that affects about two percent of the general population and six percent of people over 65 years of age.
› Verified 3 days ago
Stephanie Davis, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 481 E 1000 S, Suite D, Pleasant Grove, UT 84062 Phone: 360-808-6680 | |
Hillary Bowler Davis, AMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 135 W Center St, Pleasant Grove, UT 84062 Phone: 801-785-1169 | |
Andrea Parady, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 519 W State Rd Ste 102, Pleasant Grove, UT 84062 Phone: 385-312-9844 | |
Shirley Marie Rasmussen, MA, AMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 481 E 1000 S, Pleasant Grove, UT 84062 Phone: 801-319-1847 | |
Troy Gienger, MS, AMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 135 W Center St, Pleasant Grove, UT 84062 Phone: 801-785-1169 | |
Bryan Kubricht, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 519 W State Rd Ste 102, Pleasant Grove, UT 84062 Phone: 385-312-9844 | |
Tessa Singleton, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 196 S Main St, Pleasant Grove, UT 84062 Phone: 385-236-1974 |